Ursprung des Netzwerks ersten Grades von Mark Berninger
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark Berninger
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Morvus Technology Ltd.
Morvus Technology Ltd. Pharmaceuticals: GenericHealth Technology Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom. | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Cambridge Meditech Ltd.
Cambridge Meditech Ltd. Pharmaceuticals: MajorHealth Technology Part of Plutus Powergen Plc, Cambridge Meditech Ltd. is a company that manufactures wound infection detection products. The company is based in Cambridge, UK. Cambridge Meditech was acquired by Plutus Resources Plc on November 04, 2008 for $0.08 million. | Pharmaceuticals: Major | Director/Board Member | |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Investment Managers | Chief Investment Officer | |
IPSol Energy Ltd.
IPSol Energy Ltd. Miscellaneous Commercial ServicesCommercial Services IPSol Energy Ltd. provides business and technical solutions. The private company is based in Nottingham, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Quickend Ltd. | Director/Board Member | ||
Nick Rodgers Financial Ltd. | Director/Board Member | ||
DESTINY PHARMA PLC | Pharmaceuticals: Major | Chairman | |
CAMBRIDGE COGNITION HOLDINGS PLC | Packaged Software | Director/Board Member | |
PAION AG | Pharmaceuticals: Major | Director/Board Member | |
Serono Laboratories (UK) Ltd. | Director of Finance/CFO | ||
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Biotechnology | Director/Board Member | |
ERGOMED | Miscellaneous Commercial Services | Director/Board Member | |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Biotechnology | Chairman | |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Miscellaneous Commercial Services | Director/Board Member | |
University of Bristol | College/University | Undergraduate Degree | |
ImproveWell Ltd.
ImproveWell Ltd. Packaged SoftwareTechnology Services ImproveWell Ltd. is a digital engagement solution for healthcare improvement. The company is based in London, UK. The British company's purpose-built real-time feedback solution for health and social care allows frontline staff to capture continuous, real-time insight and quality improvement ideas. The app empowers staff to drive change, increasing staff engagement and joy in work. The company was founded in 2016 by Lara Mott, Na'eem Ahmed. Lara Mott has been the CEO since 2016. | Packaged Software | Chief Executive Officer | |
University of Leeds | College/University | Doctorate Degree | |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Pharmaceuticals: Major | Director of Finance/CFO | |
TAUC3 Biologics Ltd.
TAUC3 Biologics Ltd. BiotechnologyHealth Technology TAUC3 Biologics Ltd. is engaged in the biotechnology industry. The company was founded on July19, 2019 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Aerogen, Inc.
Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Medical Specialties | Chief Executive Officer | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Anew Optics, Inc. | Director/Board Member | ||
Glaxo AB | Corporate Officer/Principal | ||
NOVACYT | Medical Specialties | Director/Board Member | |
SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman | |
Integrated Healing Technologies LLC
Integrated Healing Technologies LLC Medical SpecialtiesHealth Technology Integrated Healing Technologies LLC develops negative pressure wound therapy devices and systems. It offers PhaseOne, advanced wound care, wound bed preparation, surgical site infection and negative pressure wound therapy. The company is headquartered in | Medical Specialties | Director/Board Member | |
University of Gothenburg | College/University | Doctorate Degree | |
XL TechGroup, Inc.
XL TechGroup, Inc. Chemicals: AgriculturalProcess Industries XL TechGroup, Inc. invests in the biotech, ecotech and medtech sectors. It also develops and commercializes proprietary insecticide and parasiticide products including non-toxic, pesticides, and anti-parasitic compounds for use in agriculture, horticulture, functional foods, healthcare, and veterinary applications. The firm involves in commercializing new technologies to grow and harvest oil from algae, an alternative to petroleum oil. The company was founded in 1993 and is located in Melbourne, FL. | Chemicals: Agricultural | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 27 |
Vereinigte Staaten | 7 |
Schweden | 4 |
China | 3 |
Irland | 2 |
Sektoral
Health Technology | 19 |
Commercial Services | 6 |
Finance | 5 |
Consumer Services | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 42 |
Corporate Officer/Principal | 11 |
Chairman | 10 |
Chief Executive Officer | 7 |
Director of Finance/CFO | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Andrew Heath | 20 |
Nick Rodgers | 18 |
Nicholas L. Woolf | 8 |
Rajan Uppal | 8 |
John Dawson | 8 |
Alexander D. Lewis | 4 |
Peter Johnson | 3 |
Lara Mott | 3 |
James Miskin | 3 |
Susan M. Kingsman | 1 |
- Börse
- Insiders
- Mark Berninger
- Unternehmensverbindungen